US5527893A
(en)
*
|
1987-09-18 |
1996-06-18 |
Genzyme Corporation |
Water insoluble derivatives of polyanionic polysaccharides
|
US6174999B1
(en)
*
|
1987-09-18 |
2001-01-16 |
Genzyme Corporation |
Water insoluble derivatives of polyanionic polysaccharides
|
US6030958A
(en)
*
|
1987-09-18 |
2000-02-29 |
Genzyme Corporation |
Water insoluble derivatives of hyaluronic acid
|
US6610669B1
(en)
*
|
1987-09-18 |
2003-08-26 |
Genzyme Corporation |
Water insoluble derivatives of polyanionic polysaccharides
|
US6235726B1
(en)
*
|
1987-09-18 |
2001-05-22 |
Genzyme Corporation |
Water insoluble derivatives of polyanionic polysaccharides
|
IT1219587B
(it)
*
|
1988-05-13 |
1990-05-18 |
Fidia Farmaceutici |
Polisaccaridi carbossiilici autoreticolati
|
US5510418A
(en)
*
|
1988-11-21 |
1996-04-23 |
Collagen Corporation |
Glycosaminoglycan-synthetic polymer conjugates
|
US5356883A
(en)
*
|
1989-08-01 |
1994-10-18 |
Research Foundation Of State University Of N.Y. |
Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
|
US5234914A
(en)
*
|
1991-06-11 |
1993-08-10 |
Patent Biopharmaceutics, Inc. |
Methods of treating hemorrhoids and anorecial disease
|
EP0544259A1
(en)
*
|
1991-11-27 |
1993-06-02 |
Lignyte Co., Ltd. |
Water insoluble biocompatible hyaluronic and polyion complex and method of making the same
|
CA2072918A1
(en)
*
|
1992-02-14 |
1993-08-15 |
Jian Qin |
Modified polysaccharides having improved absorbent properties and process for the preparation thereof
|
JP2995090B2
(ja)
*
|
1993-03-19 |
1999-12-27 |
キユー・メド・アクチエボラーグ |
組織増大のための組成物および方法
|
US5616568A
(en)
*
|
1993-11-30 |
1997-04-01 |
The Research Foundation Of State University Of New York |
Functionalized derivatives of hyaluronic acid
|
ITPD940054A1
(it)
*
|
1994-03-23 |
1995-09-23 |
Fidia Advanced Biopolymers Srl |
Polisaccaridi solfatati
|
US5585361A
(en)
|
1994-06-07 |
1996-12-17 |
Genzyme Corporation |
Methods for the inhibition of platelet adherence and aggregation
|
US5931165A
(en)
*
|
1994-09-06 |
1999-08-03 |
Fusion Medical Technologies, Inc. |
Films having improved characteristics and methods for their preparation and use
|
US6294202B1
(en)
*
|
1994-10-06 |
2001-09-25 |
Genzyme Corporation |
Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers
|
US6063396A
(en)
*
|
1994-10-26 |
2000-05-16 |
Houston Biotechnology Incorporated |
Methods and compositions for the modulation of cell proliferation and wound healing
|
US6063116A
(en)
*
|
1994-10-26 |
2000-05-16 |
Medarex, Inc. |
Modulation of cell proliferation and wound healing
|
US5498705A
(en)
*
|
1995-02-22 |
1996-03-12 |
Kimberly-Clark Corporation |
Modified polysaccharides having improved absorbent properties and process for the preparation thereof
|
US6262255B1
(en)
*
|
1995-04-05 |
2001-07-17 |
Biomm, Inc. |
Non-immunogenic, biocompatible macromolecular membrane compositions, and methods for making them
|
US5827937A
(en)
*
|
1995-07-17 |
1998-10-27 |
Q Med Ab |
Polysaccharide gel composition
|
US5897880A
(en)
*
|
1995-09-29 |
1999-04-27 |
Lam Pharmaceuticals, Llc. |
Topical drug preparations
|
US5716631A
(en)
*
|
1995-09-29 |
1998-02-10 |
Rdn Therapeutics Inc. |
Long acting narcotic analgesics and antagonists
|
US6387407B1
(en)
|
1995-09-29 |
2002-05-14 |
L.A.M. Pharmaceutical Corporation |
Topical drug preparations
|
US6251436B1
(en)
|
1995-09-29 |
2001-06-26 |
L.A.M. Pharmaceutical Corporation |
Drug preparations for treating sexual dysfunction
|
US5952006A
(en)
*
|
1995-09-29 |
1999-09-14 |
L.A.M. Pharmaceuticals, Llc |
Drug preparations for treating impotency
|
US6036977A
(en)
*
|
1995-09-29 |
2000-03-14 |
L.A.M. Pharmaceutical Corp. |
Drug preparations for treating sexual dysfunction
|
US7883693B2
(en)
*
|
1995-12-18 |
2011-02-08 |
Angiodevice International Gmbh |
Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
|
CA2239775C
(en)
*
|
1995-12-18 |
2008-07-15 |
Collagen Corporation |
Crosslinked polymer compositions and methods for their use
|
US6833408B2
(en)
*
|
1995-12-18 |
2004-12-21 |
Cohesion Technologies, Inc. |
Methods for tissue repair using adhesive materials
|
US5791352A
(en)
*
|
1996-06-19 |
1998-08-11 |
Fusion Medical Technologies, Inc. |
Methods and compositions for inhibiting tissue adhesion
|
US7435425B2
(en)
*
|
2001-07-17 |
2008-10-14 |
Baxter International, Inc. |
Dry hemostatic compositions and methods for their preparation
|
US7871637B2
(en)
|
1996-08-27 |
2011-01-18 |
Baxter International Inc. |
Dry hemostatic compositions and methods for their preparation
|
US8603511B2
(en)
|
1996-08-27 |
2013-12-10 |
Baxter International, Inc. |
Fragmented polymeric compositions and methods for their use
|
US6066325A
(en)
*
|
1996-08-27 |
2000-05-23 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
US8303981B2
(en)
|
1996-08-27 |
2012-11-06 |
Baxter International Inc. |
Fragmented polymeric compositions and methods for their use
|
US6063061A
(en)
*
|
1996-08-27 |
2000-05-16 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
FR2752843B1
(fr)
*
|
1996-08-30 |
1998-10-16 |
Sod Conseils Rech Applic |
Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
|
US8003705B2
(en)
|
1996-09-23 |
2011-08-23 |
Incept Llc |
Biocompatible hydrogels made with small molecule precursors
|
DE19712708A1
(de)
*
|
1997-03-26 |
1998-10-01 |
Thueringisches Inst Textil |
Getrocknete kontaminationsarme Hydrokolloide und Hydrogele
|
US7192984B2
(en)
*
|
1997-06-17 |
2007-03-20 |
Fziomed, Inc. |
Compositions of polyacids and polyethers and methods for their use as dermal fillers
|
US20040096422A1
(en)
*
|
1997-06-17 |
2004-05-20 |
Schwartz Herbert E. |
Compositions of polyacids and polyethers and methods for their use in reducing pain
|
US5906997A
(en)
*
|
1997-06-17 |
1999-05-25 |
Fzio Med, Inc. |
Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
|
US6869938B1
(en)
|
1997-06-17 |
2005-03-22 |
Fziomed, Inc. |
Compositions of polyacids and polyethers and methods for their use in reducing adhesions
|
US20050074495A1
(en)
*
|
1997-06-17 |
2005-04-07 |
Fziomed, Inc. |
Compositions of polyacids and methods for their use in reducing adhesions
|
US6229009B1
(en)
|
1997-08-29 |
2001-05-08 |
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) |
Polycarboxylic based cross-linked copolymers
|
US6958148B1
(en)
|
1998-01-20 |
2005-10-25 |
Pericor Science, Inc. |
Linkage of agents to body tissue using microparticles and transglutaminase
|
US6919076B1
(en)
|
1998-01-20 |
2005-07-19 |
Pericor Science, Inc. |
Conjugates of agents and transglutaminase substrate linking molecules
|
US6630457B1
(en)
|
1998-09-18 |
2003-10-07 |
Orthogene Llc |
Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
|
EP1137373A4
(en)
|
1998-12-04 |
2004-05-19 |
Chandrashekhar P Pathak |
BIOCOMPATIBLE, CROSSLINKED POLYMERS
|
FR2790391B1
(fr)
|
1999-03-02 |
2002-11-15 |
Flamel Tech Sa |
Moyen pour la prevention des adherences post-chirurgicales,a base de peptides collagenique reticule
|
WO2000054762A2
(en)
*
|
1999-03-15 |
2000-09-21 |
Trustees Of Boston University |
Use of cross linked polysaccharides for the inhibition of angiogenesis
|
US20040048021A1
(en)
*
|
1999-03-19 |
2004-03-11 |
Wan Barbara Y. F. |
Surface modification of substrates
|
CA2366897C
(en)
*
|
1999-04-06 |
2009-11-17 |
Andrew B. Onderdonk |
Immunomodulatory compositions and methods of use thereof
|
FR2799196B1
(fr)
|
1999-10-04 |
2002-02-08 |
Sod Conseils Rech Applic |
Copolymeres reticules a base de copolymeres polycarboxyliques non reticules
|
US7651703B2
(en)
*
|
1999-10-15 |
2010-01-26 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
US7582311B1
(en)
|
1999-10-15 |
2009-09-01 |
Genentech, Inc. |
Injection vehicle for polymer-based formulations
|
EP1228771A4
(en)
*
|
1999-11-09 |
2003-01-29 |
Denki Kagaku Kogyo Kk |
USE OF SOLUBLE CELLULOSE DERIVATIVES MADE DIFFICULTLY SOLUBLE IN WATER AND METHOD OF PREPARING SUCH DERIVATIVES
|
US20030211166A1
(en)
*
|
2001-07-31 |
2003-11-13 |
Yamamoto Ronald K |
Microparticulate biomaterial composition for medical use
|
ATE283715T1
(de)
|
1999-12-17 |
2004-12-15 |
Genzyme Corp |
Chirurgische prothese
|
CA2397578A1
(en)
|
1999-12-21 |
2001-06-28 |
Ajinomoto Co., Inc. |
A partial ester of a nitrogenous carboxylic acid with cellulose and a process for preparing the same
|
US6566345B2
(en)
|
2000-04-28 |
2003-05-20 |
Fziomed, Inc. |
Polyacid/polyalkylene oxide foams and gels and methods for their delivery
|
AU778318B2
(en)
*
|
2000-02-03 |
2004-11-25 |
Tissuemed Limited |
Device for the closure of a surgical puncture
|
US6521223B1
(en)
*
|
2000-02-14 |
2003-02-18 |
Genzyme Corporation |
Single phase gels for the prevention of adhesions
|
US6749865B2
(en)
*
|
2000-02-15 |
2004-06-15 |
Genzyme Corporation |
Modification of biopolymers for improved drug delivery
|
ATE425776T1
(de)
*
|
2000-04-28 |
2009-04-15 |
Fziomed Inc |
Haemostatische zusammenstellung von polysauren und polyalkylenoxyden und deren verwendungsmethoden
|
ES2275739T3
(es)
*
|
2000-08-02 |
2007-06-16 |
AESCULAP AG & CO. KG |
Producto medico-tecnico, procedimiento para su produccion y puesta a disposicion para la cirugia.
|
AU2001286701A1
(en)
*
|
2000-08-31 |
2002-03-13 |
Genzyme Biosurgery Corporation |
Hyaluronan-based antiadhesion compositions, their preparation and use
|
KR100375299B1
(ko)
|
2000-10-10 |
2003-03-10 |
주식회사 엘지생명과학 |
히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
|
DK1328300T3
(da)
*
|
2000-10-23 |
2005-03-21 |
Tissuemed Ltd |
Selvklæbende hydratiserbar matrix til topisk terapeutisk anvendelse
|
WO2002066543A1
(en)
*
|
2001-02-16 |
2002-08-29 |
Genzyme Corporation |
Method of drying a material having a cohesive phase
|
CA2437417C
(en)
*
|
2001-02-22 |
2016-07-26 |
Anika Therapeutics, Inc. |
Thiol-modified hyaluronan
|
US20020172712A1
(en)
*
|
2001-03-19 |
2002-11-21 |
Alan Drizen |
Antiemetic, anti-motion sustained release drug delivery system
|
US20030138494A1
(en)
*
|
2001-05-15 |
2003-07-24 |
L.A.M. Pharmaceutical Corporation |
Drug preparations for treating sexual dysfunction
|
AU2002367394A1
(en)
*
|
2001-12-28 |
2003-07-24 |
Genzyme Corporation |
Bioresorbable foam packing device and use thereof
|
JP2005530768A
(ja)
*
|
2002-05-09 |
2005-10-13 |
メディジーンズ |
血漿または血清を含有した創傷治療用医薬組成物
|
US7299805B2
(en)
*
|
2002-06-07 |
2007-11-27 |
Marctec, Llc |
Scaffold and method for implanting cells
|
EP1539193A4
(en)
*
|
2002-07-03 |
2010-05-05 |
Pericor Science Inc |
HYALURONIC ACID COMPOSITIONS AND METHODS OF USE
|
AU2003264498A1
(en)
*
|
2002-09-18 |
2004-04-08 |
Wakamoto Pharmaceutical Co., Ltd. |
Transparent and reversibly heat-gelling aqueous compositions
|
US8673333B2
(en)
*
|
2002-09-25 |
2014-03-18 |
The Johns Hopkins University |
Cross-linked polymer matrices, and methods of making and using same
|
US7862831B2
(en)
*
|
2002-10-09 |
2011-01-04 |
Synthasome, Inc. |
Method and material for enhanced tissue-biomaterial integration
|
US20050069572A1
(en)
*
|
2002-10-09 |
2005-03-31 |
Jennifer Elisseeff |
Multi-layered polymerizing hydrogels for tissue regeneration
|
TWI251596B
(en)
*
|
2002-12-31 |
2006-03-21 |
Ind Tech Res Inst |
Method for producing a double-crosslinked hyaluronate material
|
WO2004063181A1
(en)
|
2003-01-03 |
2004-07-29 |
Genzyme Corporation |
Urea derivatives and their use as anti-inflammatory agents
|
US8137688B2
(en)
*
|
2003-01-10 |
2012-03-20 |
The Cleveland Clinic Foundation |
Hydroxyphenyl cross-linked macromolecular network and applications thereof
|
US6982298B2
(en)
*
|
2003-01-10 |
2006-01-03 |
The Cleveland Clinic Foundation |
Hydroxyphenyl cross-linked macromolecular network and applications thereof
|
US7465766B2
(en)
*
|
2004-01-08 |
2008-12-16 |
The Cleveland Clinic Foundation |
Hydroxyphenyl cross-linked macromolecular network and applications thereof
|
US8138265B2
(en)
*
|
2003-01-10 |
2012-03-20 |
The Cleveland Clinic Foundation |
Hydroxyphenyl cross-linked macromolecular network and applications thereof
|
MXPA05010692A
(es)
*
|
2003-04-04 |
2006-04-18 |
Tissuemed Ltd |
Formulaciones que se adhieren a tejido.
|
FR2861734B1
(fr)
|
2003-04-10 |
2006-04-14 |
Corneal Ind |
Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
|
US8834864B2
(en)
*
|
2003-06-05 |
2014-09-16 |
Baxter International Inc. |
Methods for repairing and regenerating human dura mater
|
JP4690892B2
(ja)
*
|
2003-06-30 |
2011-06-01 |
電気化学工業株式会社 |
脊椎・脊髄手術用癒着防止材
|
PL1654002T5
(pl)
*
|
2003-08-07 |
2014-06-30 |
Allergan Inc |
Kompozycje do dostarczania środków terapeutycznych do oczu
|
US7927626B2
(en)
*
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
US7625581B2
(en)
*
|
2003-12-19 |
2009-12-01 |
Ethicon, Inc. |
Tissue scaffolds for use in muscoloskeletal repairs
|
US7091191B2
(en)
*
|
2003-12-19 |
2006-08-15 |
Ethicon, Inc. |
Modified hyaluronic acid for use in musculoskeletal tissue repair
|
JP2005261608A
(ja)
*
|
2004-03-18 |
2005-09-29 |
Masato Kusunoki |
薬物を担持した生体吸収性ゲル、パウダーおよびフィルム
|
EP1744796B1
(en)
|
2004-04-20 |
2015-03-18 |
Genzyme Corporation |
Surgical mesh-like implant
|
KR101148445B1
(ko)
|
2004-04-28 |
2012-07-05 |
안지오디바이스 인터내셔널 게엠베하 |
가교된 생합성물질을 형성하기 위한 조성물 및 시스템, 및 이와 관련된 제조 및 사용 방법
|
EP1595528A1
(de)
*
|
2004-05-14 |
2005-11-16 |
Fibona Health Products GmbH |
Hyaferm-Komposite
|
BRPI0514106A
(pt)
*
|
2004-08-03 |
2008-05-27 |
Tissuemed Ltd |
materiais adesivos a tecidos
|
US7858107B2
(en)
*
|
2004-09-10 |
2010-12-28 |
Medtronic Xomed, Inc. |
Flexible bioresorbable hemostatic packing and stent having a preselectable in-vivo residence time
|
US8303973B2
(en)
|
2004-09-17 |
2012-11-06 |
Angiotech Pharmaceuticals (Us), Inc. |
Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
|
US20060069063A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Yng-Jiin Wang |
Crosslinked polygalacturonic acid used for postsurgical tissue adhesion prevention
|
EP1819297B1
(en)
|
2004-09-28 |
2015-01-14 |
Atrium Medical Corporation |
Uv cured gel and method of making
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
US9801982B2
(en)
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
WO2006036982A2
(en)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Drug delivery coating for use with a stent
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
US8367099B2
(en)
|
2004-09-28 |
2013-02-05 |
Atrium Medical Corporation |
Perforated fatty acid films
|
US8312836B2
(en)
*
|
2004-09-28 |
2012-11-20 |
Atrium Medical Corporation |
Method and apparatus for application of a fresh coating on a medical device
|
US8481080B2
(en)
|
2004-11-24 |
2013-07-09 |
Novozymes Biopolymer A/S |
Method of cross-linking hyaluronic acid with divinulsulfone
|
CN1325125C
(zh)
*
|
2004-12-23 |
2007-07-11 |
中国人民解放军第二军医大学 |
一种防粘连生物膜
|
ITTO20040918A1
(it)
*
|
2004-12-29 |
2005-03-29 |
Luigi Ambrosio |
Idrogel polimerici superassorbenti biodegradabili e procedimento per la loro preparazione
|
WO2006089119A2
(en)
*
|
2005-02-18 |
2006-08-24 |
Cartilix, Inc. |
Biological adhesive
|
EP1911769B1
(en)
|
2005-08-04 |
2013-10-30 |
Teijin Limited |
Cellulose derivative
|
US7323184B2
(en)
*
|
2005-08-22 |
2008-01-29 |
Healagenics, Inc. |
Compositions and methods for the treatment of wounds and the reduction of scar formation
|
US9278161B2
(en)
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
AU2006304590A1
(en)
|
2005-10-15 |
2007-04-26 |
Atrium Medical Corporation |
Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
|
US20070110788A1
(en)
*
|
2005-11-14 |
2007-05-17 |
Hissong James B |
Injectable formulation capable of forming a drug-releasing device
|
CA2640629A1
(en)
|
2006-02-03 |
2007-08-09 |
Tissuemed Limited |
Tissue-adhesive materials
|
US20090018575A1
(en)
*
|
2006-03-01 |
2009-01-15 |
Tissuemed Limited |
Tissue-adhesive formulations
|
EP2001529A4
(en)
*
|
2006-03-21 |
2011-11-09 |
Agency Science Tech & Res |
MATERIAL FOR CELLULAR ADHESION POLYELECTROLYTE FOR USE AS MEMBRANE AND COATING
|
US20080069857A1
(en)
*
|
2006-04-12 |
2008-03-20 |
Yoon Yeo |
Compositions And Methods For Inhibiting Adhesions
|
US7959943B2
(en)
*
|
2006-05-10 |
2011-06-14 |
Medtronics Xomed, Inc. |
Solvating system and sealant for medical use in the middle or inner ear
|
US7993675B2
(en)
|
2006-05-10 |
2011-08-09 |
Medtronic Xomed, Inc. |
Solvating system and sealant for medical use in the sinuses and nasal passages
|
US7976873B2
(en)
*
|
2006-05-10 |
2011-07-12 |
Medtronic Xomed, Inc. |
Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
|
US20070264296A1
(en)
*
|
2006-05-10 |
2007-11-15 |
Myntti Matthew F |
Biofilm extracellular polysachharide solvating system
|
CA2651941C
(en)
*
|
2006-05-31 |
2015-02-17 |
Baxter International Inc. |
Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
|
US8313762B2
(en)
*
|
2006-07-05 |
2012-11-20 |
Medtronic Xomed, Inc. |
Flexible bioresorbable hemostatic packing and stent
|
TWI436793B
(zh)
*
|
2006-08-02 |
2014-05-11 |
Baxter Int |
快速作用之乾密封膠及其使用和製造方法
|
ITMI20061726A1
(it)
*
|
2006-09-11 |
2008-03-12 |
Fidia Farmaceutici |
Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry
|
JP2010508897A
(ja)
|
2006-11-06 |
2010-03-25 |
アトリウム メディカル コーポレーション |
コーティングされた外科用メッシュ
|
US9492596B2
(en)
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
US8114159B2
(en)
*
|
2006-11-20 |
2012-02-14 |
Depuy Spine, Inc. |
Anterior spinal vessel protector
|
JP5242921B2
(ja)
*
|
2007-02-06 |
2013-07-24 |
帝人株式会社 |
ホスファチジルエタノールアミン結合多糖類の製造方法
|
US8455001B2
(en)
|
2007-02-06 |
2013-06-04 |
Teijin Limited |
Cellulose derivative and method for production thereof
|
US8088095B2
(en)
*
|
2007-02-08 |
2012-01-03 |
Medtronic Xomed, Inc. |
Polymeric sealant for medical use
|
US8658148B2
(en)
|
2007-06-22 |
2014-02-25 |
Genzyme Corporation |
Chemically modified dendrimers
|
GB0715514D0
(en)
*
|
2007-08-10 |
2007-09-19 |
Tissuemed Ltd |
Coated medical devices
|
MX2010004838A
(es)
|
2007-10-30 |
2010-05-21 |
Baxter Int |
Uso de una biomatriz de colageno biofuncional regenerativa para tratar defectos viscerales o parietales.
|
BRPI0819075A2
(pt)
|
2007-11-16 |
2014-10-07 |
Vicept Therapeutics Inc |
Método para tratar púrpura em um indivíduo e método para diminuir a púrpura em um indivíduo antes de um procedimento cirúrgico
|
US9345809B2
(en)
*
|
2007-11-28 |
2016-05-24 |
Fziomed, Inc. |
Carboxymethylcellulose polyethylene glycol compositions for medical uses
|
US8394782B2
(en)
|
2007-11-30 |
2013-03-12 |
Allergan, Inc. |
Polysaccharide gel formulation having increased longevity
|
EP2222715B1
(en)
*
|
2007-12-19 |
2019-07-24 |
Evonik Degussa GmbH |
Crosslinked hyaluronic acid in emulsion
|
WO2009102967A2
(en)
|
2008-02-13 |
2009-08-20 |
The Cleveland Clinic Foundation |
Molecular enhancement of extracellular matrix and methods of use
|
WO2009108760A2
(en)
|
2008-02-26 |
2009-09-03 |
Board Of Regents, The University Of Texas System |
Dendritic macroporous hydrogels prepared by crystal templating
|
CA2716872C
(en)
|
2008-02-29 |
2015-02-10 |
Ferrosan Medical Devices A/S |
Device for promotion of hemostasis and/or wound healing
|
US9192571B2
(en)
*
|
2008-03-03 |
2015-11-24 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating or preventing ocular pain
|
US7842714B2
(en)
|
2008-03-03 |
2010-11-30 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating ocular pain
|
US8410180B2
(en)
*
|
2008-04-30 |
2013-04-02 |
The Cleveland Clinic Foundation |
Methods to treat urinary incontinence
|
WO2009148985A2
(en)
*
|
2008-06-03 |
2009-12-10 |
E. I. Du Pont De Nemours And Company |
A tissue coating for preventing undesired tissue-to-tissue adhesions
|
WO2009152374A2
(en)
|
2008-06-12 |
2009-12-17 |
Medtronic Xomed, Inc. |
Method for treating chronic wounds
|
US8450475B2
(en)
|
2008-08-04 |
2013-05-28 |
Allergan, Inc. |
Hyaluronic acid-based gels including lidocaine
|
CA2731791A1
(en)
*
|
2008-08-05 |
2010-02-11 |
Teijin Limited |
Hydrogel
|
EP3184552B1
(en)
|
2008-09-02 |
2020-08-12 |
Tautona Group LP |
Threads of hyaluronic acid, methods of making thereof and uses thereof
|
EP2346324A4
(en)
|
2008-10-06 |
2012-10-10 |
Microbial Defense Systems Llc |
ANTIMICROBIAL COMPOSITION AND METHODS OF MAKING AND USING
|
US9039783B2
(en)
*
|
2009-05-18 |
2015-05-26 |
Baxter International, Inc. |
Method for the improvement of mesh implant biocompatibility
|
JP5719355B2
(ja)
*
|
2009-06-16 |
2015-05-20 |
バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated |
止血スポンジ
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
KR101811070B1
(ko)
|
2009-12-16 |
2017-12-20 |
백스터 인터내셔널 인코포레이티드 |
지혈 스폰지
|
JP5686297B2
(ja)
|
2009-12-28 |
2015-03-18 |
川澄化学工業株式会社 |
癒着防止材
|
US20110172180A1
(en)
|
2010-01-13 |
2011-07-14 |
Allergan Industrie. Sas |
Heat stable hyaluronic acid compositions for dermatological use
|
US9114188B2
(en)
|
2010-01-13 |
2015-08-25 |
Allergan, Industrie, S.A.S. |
Stable hydrogel compositions including additives
|
NZ602405A
(en)
|
2010-03-12 |
2014-12-24 |
Allergan Ind Sas |
A fluid composition comprising a hyaluronan polymer and mannitol for improving skin conditions
|
AU2011229730B2
(en)
|
2010-03-22 |
2016-01-07 |
Allergan, Inc. |
Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
|
SA111320355B1
(ar)
|
2010-04-07 |
2015-01-08 |
Baxter Heathcare S A |
إسفنجة لايقاف النزف
|
CA2801120C
(en)
|
2010-06-01 |
2019-08-20 |
Baxter International Inc. |
Process for making dry and stable hemostatic compositions
|
AU2011260260B2
(en)
|
2010-06-01 |
2015-09-03 |
Baxter Healthcare S.A. |
Process for making dry and stable hemostatic compositions
|
EP2575775B1
(en)
|
2010-06-01 |
2018-04-04 |
Baxter International Inc. |
Process for making dry and stable hemostatic compositions
|
US10322213B2
(en)
|
2010-07-16 |
2019-06-18 |
Atrium Medical Corporation |
Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
|
US8883139B2
(en)
|
2010-08-19 |
2014-11-11 |
Allergan Inc. |
Compositions and soft tissue replacement methods
|
US8889123B2
(en)
|
2010-08-19 |
2014-11-18 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US9005605B2
(en)
|
2010-08-19 |
2015-04-14 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US8946194B2
(en)
|
2010-10-08 |
2015-02-03 |
Board Of Regents, University Of Texas System |
One-step processing of hydrogels for mechanically robust and chemically desired features
|
JP6042815B2
(ja)
|
2010-10-08 |
2016-12-14 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム |
生物医学的応用のためのアルギン酸塩及びヒアルロン酸を用いる抗癒着性バリア膜
|
AU2012253476B2
(en)
|
2011-05-10 |
2015-09-24 |
Next Science IP Holdings Pty Ltd |
Antimicrobial solid and methods of making and using same
|
US9393263B2
(en)
|
2011-06-03 |
2016-07-19 |
Allergan, Inc. |
Dermal filler compositions including antioxidants
|
US20130096081A1
(en)
|
2011-06-03 |
2013-04-18 |
Allergan, Inc. |
Dermal filler compositions
|
US9408797B2
(en)
|
2011-06-03 |
2016-08-09 |
Allergan, Inc. |
Dermal filler compositions for fine line treatment
|
EP3536307B1
(en)
|
2011-06-03 |
2021-10-20 |
ALLERGAN Industrie, SAS |
Dermal filler compositions including antioxidants
|
LT2742070T
(lt)
|
2011-08-10 |
2021-10-25 |
Glycores 2000 Srl |
Degradacijai atsparus tinklinis mažos molekulinės masės hialuronatas
|
US20130244943A1
(en)
|
2011-09-06 |
2013-09-19 |
Allergan, Inc. |
Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
|
US9662422B2
(en)
|
2011-09-06 |
2017-05-30 |
Allergan, Inc. |
Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
|
ES2938566T3
(es)
|
2011-10-11 |
2023-04-12 |
Baxter Int |
Composiciones hemostaticas
|
KR102102002B1
(ko)
|
2011-10-11 |
2020-04-20 |
백스터 인터내셔널 인코포레이티드 |
지혈 조성물
|
SA112330957B1
(ar)
|
2011-10-27 |
2015-08-09 |
باكستر انترناشونال انك. |
تركيبات لإيقاف النزف
|
RU2657955C2
(ru)
|
2012-03-06 |
2018-06-18 |
Ферросан Медикал Дивайсиз А/С |
Контейнер под давлением, содержащий гемостатическую пасту
|
FR2988585B1
(fr)
|
2012-03-28 |
2015-04-03 |
Cousin Biotech |
Plaque viscerale destinee a la coelioscopie
|
BR112014030962A2
(pt)
|
2012-06-12 |
2017-06-27 |
Ferrosan Medical Devices As |
métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
CN104981259B
(zh)
|
2012-12-11 |
2017-03-08 |
得克萨斯系统大学评议会 |
包含防粘连的水凝胶膜的试剂盒
|
US11565027B2
(en)
|
2012-12-11 |
2023-01-31 |
Board Of Regents, The University Of Texas System |
Hydrogel membrane for adhesion prevention
|
US20140221309A1
(en)
|
2013-02-01 |
2014-08-07 |
Allergan, Inc. |
Eye drop formulation with enhanced properties by combining sodium hyaluronate with carboxymethylcellulose
|
US20140315828A1
(en)
|
2013-04-22 |
2014-10-23 |
Allergan, Inc. |
Cross-linked silk-hyaluronic acid compositions
|
RU2700162C2
(ru)
|
2013-06-21 |
2019-09-13 |
Ферросан Медикал Дивайсиз А/С |
Расширенная под вакуумом сухая композиция и шприц для ее сохранения
|
EP3470094B1
(en)
|
2013-12-11 |
2020-07-22 |
Ferrosan Medical Devices A/S |
Dry composition comprising an extrusion enhancer
|
EP3200838B1
(en)
|
2014-09-30 |
2019-09-18 |
Allergan Industrie, SAS |
Stable hydrogel compositions including additives
|
CA2960309A1
(en)
|
2014-10-13 |
2016-04-21 |
Ferrosan Medical Devices A/S |
Dry composition for use in haemostasis and wound healing
|
CN107206165B
(zh)
|
2014-12-24 |
2020-10-23 |
弗罗桑医疗设备公司 |
用于保持并混合第一和第二物质的注射器
|
WO2016128783A1
(en)
|
2015-02-09 |
2016-08-18 |
Allergan Industrie Sas |
Compositions and methods for improving skin appearance
|
AU2016290433B2
(en)
|
2015-07-03 |
2018-05-24 |
Ferrosan Medical Devices A/S |
Syringe for mixing two components and for retaining a vacuum in a storage condition
|
CN105381501A
(zh)
*
|
2015-12-15 |
2016-03-09 |
日照天一生物医疗科技有限公司 |
可降解生物复合止血膜及其制备方法
|
WO2018039496A1
(en)
|
2016-08-24 |
2018-03-01 |
Allergan, Inc. |
Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation
|
WO2018165327A1
(en)
|
2017-03-08 |
2018-09-13 |
Alafair Biosciences, Inc. |
Hydrogel medium for the storage and preservation of tissue
|
WO2019215274A1
(en)
|
2018-05-09 |
2019-11-14 |
Ferrosan Medical Devices A/S |
Method for preparing a haemostatic composition
|
JP7311983B2
(ja)
*
|
2019-03-01 |
2023-07-20 |
大日本印刷株式会社 |
ゲル膜の製造方法およびゲル膜
|
JP7396804B2
(ja)
*
|
2019-03-01 |
2023-12-12 |
大日本印刷株式会社 |
ゲル膜の製造方法およびゲル膜
|
RU2744752C1
(ru)
*
|
2020-08-28 |
2021-03-15 |
Федеральное государственное бюджетное учреждение науки Институт проблем химико-энергетических технологий Сибирского отделения Российской академии наук (ИПХЭТ СО РАН) |
Способ получения противоспаечного материала
|
WO2023030435A1
(en)
|
2021-09-01 |
2023-03-09 |
Shanghai Qisheng Biological Preparation Co., Ltd. |
Cartilage regeneration using injectable, in situ polymerizable collagen compositions containing chondrocytes or stem cells
|
WO2023056433A1
(en)
*
|
2021-10-01 |
2023-04-06 |
Northwestern University |
Supramolecular-covalent composite slurry for cartilage repair
|